CELGENE CP CELG (NASDAQ) $ 67.15 Change: -0.34 -0.51% | Volume: 2,924,090

CELGENE CORP - Fundamental Profile

Company Information

Ticker Symbol: CELG
Exchange: NASD
Contact Info: 86 Morris Avenue Summit NJ 07901 908 673-9000
CEO/President: Sol J. Barer
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Share Information

Shares Outstanding: 435,870 (000) Market Value: 31,132,260 ($000)
Percentage of Inst.Shareholders: 81.89% Number of Inst.Shareholders: 2.40%
Last Quarter Sales: 571.46 ($Mil.) Last Quarter Net Income: 119.88 ($Mil.)
Last Quarter EPS: 0.31 P/E Ratio: 56
Most Recent Earnings: 0.37 on 07/24/08 Earnings Per Share: -3.45
Most Recent Split: 2-1 on 02/27/06 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +36.90 63.10
GILEAD SCIENCES +27.50 51.38
AMYLIN PHARMA I -53.60 22.27
BIOGEN IDEC INC -16.80 50.17
GENENTECH INC +35.90 97.68